Free Trial
NYSE:FMS

Fresenius Medical Care Q1 2025 Earnings Report

Fresenius Medical Care logo
$25.62 +0.60 (+2.40%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$25.58 -0.04 (-0.14%)
As of 05/2/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Fresenius Medical Care EPS Results

Actual EPS
N/A
Consensus EPS
$0.45
Beat/Miss
N/A
One Year Ago EPS
N/A

Fresenius Medical Care Revenue Results

Actual Revenue
N/A
Expected Revenue
$4.71 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Fresenius Medical Care Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Tuesday, May 6, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

Fresenius Medical Care Earnings Headlines

Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
See More Fresenius Medical Care Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fresenius Medical Care? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fresenius Medical Care and other key companies, straight to your email.

About Fresenius Medical Care

Fresenius Medical Care (NYSE:FMS) provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

View Fresenius Medical Care Profile

More Earnings Resources from MarketBeat